Delivery Order SPE2DB22D2009-SPE2DB25FM0QA
- Not listed
- This federal contract award to AmerisourceBergen Drug Corp (AmerisourceBergen) is a $2,345.55 Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) for the supply of 0.5% Refresh Tears eye drops in 15ml bottles. The contract has a period of performance through June 14, 2024 and was awarded on June 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Refresh Tears 0.5% eye drops. The $1,254.10 firm fixed-price contract has an ultimate completion date of April 29, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Refresh Tears 0.5% eye drops (15 ml). The contract has a ceiling value of $1,773.60 and runs through November 7, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999, which serves as a primary vehicle for supplying a wide range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,227.39 firm-fixed-price delivery order is for the supply of 0.5% Refresh Tears eye drops in 15 ml bottles. The contract has an ultimate completion date of September 29, 2022 and was awarded on September 28, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between...
- This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,360.12, is for the delivery of Refresh Tears 0.5% eye drops in 15 milliliter bottles. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of February 24, 2023. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp...
- This federal contract award is for a one-year delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 0.5% Refresh Tears eye drops in 15 ml bottles. The $1,033.98 firm-fixed-price contract does not have a set-aside designation, indicating open competition. This contract is a child order under a larger Indefinite Delivery Contract (IDC) vehicle valued at $999,999,999 held by AmerisourceBergen with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,043.05 Firm Fixed Price Delivery Order is for the supply of Refresh Tears 0.5% eye drops, a medical commodity primarily used to support military and veteran healthcare programs. The contract has no set-aside designation, indicating open competition. Amerisourcebergen, a subsidiary of the parent company Cencora,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,162.81 Firm Fixed Price Delivery Order contract is for the supply of Refresh Tears 0.5% eye drops, a common ophthalmic medication. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- This is a $3,419.03 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Refresh Tears 0.5% eye drops in 15ml bottles. The contract has an ultimate completion date of May 23, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp is a for-profit corporate entity that serves as a critical supplier of medical and pharmaceutical products to federal agencies,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Refresh Tears 0.5% eye drops in 15 milliliter bottles. The firm-fixed-price contract has a ceiling value of $2,474.50 and a period of performance through May 21, 2025. The contract was not set aside for small businesses. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM0QADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Refresh Tears 0.5% eye drops (15 mL) with a ceiling value of $1,277.84 under a firm fixed-price contract structure. This is a non-set-aside award issued on July 31, 2025, with an ultimate completion date of August 1, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's comprehensive IDC with DLA enables it to supply a broad range of pharmaceutical products and medical supplies across multiple therapeutic categories to support Department of Defense healthcare programs globally. All of AmerisourceBergen's reviewed federal contract awards have been competitively awarded without set-asides, demonstrating the company's capability to meet federal procurement standards through open competition. This delivery order for ophthalmic medication reflects the company's ongoing role in supplying essential medical commodities to support military readiness and healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/31/25 |